Pathogenic Basis of Thromboinflammation and Endothelial Injury in COVID-19: Current Findings and Therapeutic Implications
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic with a great impact on social and economic activities, as well as public health. In most patients, the symptoms of COVID-19 are a high-grade fever and a dry cough...
Guardado en:
Autores principales: | Yasutomi Higashikuni, Wenhao Liu, Takumi Obana, Masataka Sata |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/59141037c0a5495ebe7b794ba22ab4ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Brain injury, endothelial injury and inflammatory markers are elevated and express sex-specific alterations after COVID-19
por: Jude Savarraj, et al.
Publicado: (2021) -
Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
por: Jonas Nascimento Conde, et al.
Publicado: (2020) -
Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells
por: Francesca Benedetti, et al.
Publicado: (2021) -
Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19
por: Vanessa Bianconi, et al.
Publicado: (2021) -
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
por: Kavya Srinivasan, et al.
Publicado: (2021)